ResMed (RMD)

EBITDA Margin

38.33%

TTM · Period ending:

RMD logo

RMD EBITDA Margin

Latest reported38.08%
RMD FY EBITDA Margin (11.69% → 38.08%)
High-resolution chart · PNG

RMD ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

ResMed EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
38.0761%
37.1795%
32.731%
32.2009%
32.8841%
34.5302%
33.4943%
27.0776%
29.0669%
27.526%
28.4283%
28.7265%
31.1817%
31.0201%
30.8792%
30.1109%
29.7356%
27.7655%
24.5192%
12.5868%
28.6728%
32.1733%
25.1552%
29.1783%
-20.0107%
33.6204%
34.0665%
33.7472%
31.5789%
22.1545%
14.1618%
14.4681%
11.5108%
11.6883%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.